Katchman BA - Search Results

1

Proteomic mapping of p53 immunogenicity in pancreatic, ovarian, and breast cancers.

Katchman BA, Barderas R, Alam R, Chowell D, Field MS, Esserman LJ, Wallstrom G, LaBaer J, Cramer DW, Hollingsworth MA, Anderson KS. Katchman BA, et al. Proteomics Clin Appl. 2016 Jul;10(7):720-31. doi: 10.1002/prca.201500096. Epub 2016 May 17. Proteomics Clin Appl. 2016. PMID: 27121307 Free PMC article.

2

Programmable protein arrays for immunoprofiling HPV-associated cancers.

Ewaisha R, Meshay I, Resnik J, Katchman BA, Anderson KS. Ewaisha R, et al. Among authors: katchman ba. Proteomics. 2016 Apr;16(8):1215-24. doi: 10.1002/pmic.201500376. Epub 2016 Apr 4. Proteomics. 2016. PMID: 27089055 Free PMC article.

3

Autoantibody biomarkers for the detection of serous ovarian cancer.

Katchman BA, Chowell D, Wallstrom G, Vitonis AF, LaBaer J, Cramer DW, Anderson KS. Katchman BA, et al. Gynecol Oncol. 2017 Jul;146(1):129-136. doi: 10.1016/j.ygyno.2017.04.005. Epub 2017 Apr 18. Gynecol Oncol. 2017. PMID: 28427776 Free PMC article.

4

Eccrine Sweat as a Biofluid for Profiling Immune Biomarkers.

Katchman BA, Zhu M, Blain Christen J, Anderson KS. Katchman BA, et al. Proteomics Clin Appl. 2018 Nov;12(6):e1800010. doi: 10.1002/prca.201800010. Epub 2018 Jun 28. Proteomics Clin Appl. 2018. PMID: 29882373 Free PMC article.

5

Application of flat panel OLED display technology for the point-of-care detection of circulating cancer biomarkers.

Katchman BA, Smith JT, Obahiagbon U, Kesiraju S, Lee YK, O'Brien B, Kaftanoglu K, Blain Christen J, Anderson KS. Katchman BA, et al. Sci Rep. 2016 Jul 4;6:29057. doi: 10.1038/srep29057. Sci Rep. 2016. PMID: 27374875 Free PMC article.

6

A compact, low-cost, quantitative and multiplexed fluorescence detection platform for point-of-care applications.

Obahiagbon U, Smith JT, Zhu M, Katchman BA, Arafa H, Anderson KS, Blain Christen JM. Obahiagbon U, et al. Among authors: katchman ba. Biosens Bioelectron. 2018 Oct 15;117:153-160. doi: 10.1016/j.bios.2018.04.002. Epub 2018 Apr 4. Biosens Bioelectron. 2018. PMID: 29894852 Free PMC article.

7

Quiescin sulfhydryl oxidase 1 promotes invasion of pancreatic tumor cells mediated by matrix metalloproteinases.

Katchman BA, Antwi K, Hostetter G, Demeure MJ, Watanabe A, Decker GA, Miller LJ, Von Hoff DD, Lake DF. Katchman BA, et al. Mol Cancer Res. 2011 Dec;9(12):1621-31. doi: 10.1158/1541-7786.MCR-11-0018. Epub 2011 Oct 11. Mol Cancer Res. 2011. PMID: 21989104

8

Ebselen inhibits QSOX1 enzymatic activity and suppresses invasion of pancreatic and renal cancer cell lines.

Hanavan PD, Borges CR, Katchman BA, Faigel DO, Ho TH, Ma CT, Sergienko EA, Meurice N, Petit JL, Lake DF. Hanavan PD, et al. Among authors: katchman ba. Oncotarget. 2015 Jul 30;6(21):18418-28. doi: 10.18632/oncotarget.4099. Oncotarget. 2015. PMID: 26158899 Free PMC article.

9

Analysis of the plasma peptidome from pancreas cancer patients connects a peptide in plasma to overexpression of the parent protein in tumors.

Antwi K, Hostetter G, Demeure MJ, Katchman BA, Decker GA, Ruiz Y, Sielaff TD, Koep LJ, Lake DF. Antwi K, et al. Among authors: katchman ba. J Proteome Res. 2009 Oct;8(10):4722-31. doi: 10.1021/pr900414f. J Proteome Res. 2009. PMID: 19795908

10

Expression of quiescin sulfhydryl oxidase 1 is associated with a highly invasive phenotype and correlates with a poor prognosis in Luminal B breast cancer.

Katchman BA, Ocal IT, Cunliffe HE, Chang YH, Hostetter G, Watanabe A, LoBello J, Lake DF. Katchman BA, et al. Breast Cancer Res. 2013 Mar 28;15(2):R28. doi: 10.1186/bcr3407. Breast Cancer Res. 2013. PMID: 23536962 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page